Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia.

NCT05672888 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Jaktinib
DRUG: Placebo

Sponsor

First Affiliated Hospital of Zhejiang University